Can a new drug mimic the effects of exercise on bone and muscle?
Researchers have recently discovered that a new drug called locamidazole may help to prevent loss of bone density and muscle mass during periods of inactivity, but it’s no substitute for all of the benefits of exercise.
Finding the right fit in a psychotherapist
When it comes to therapy, the quality of the patient-therapist relationship is critical to success.
A recent metformin study casts doubts on longevity indications
A new retrospective study contradicts previous evidence of metformin’s potential effects on lifespan extension in a general population, but for real answers, randomized trials are needed.
More hype than substance: erythritol and cardiovascular risk
A newly-published study caught public attention by reporting an association between the common sweetener erythritol and increased risk of heart attack and stroke, but there’s more to the story.
Lean mass loss on GLP-1 receptor agonists: a downside of the “miracle drugs”
Clinical trials have generated impressive data on the effects of GLP-1 agonists on body weight and BMI, but how do these drugs perform in terms of body composition?
Screen time and children’s cognition: a question of context
A recent review suggests that screen time may not be as bad for infants as many of us may think – but only under the right circumstances.
The dangers of “healthy” addictions
Though exercise has virtually unlimited health benefits, addiction to exercise can be a danger to mental and physical well-being. But what distinguishes exercise addiction from healthy engagement in physical activity?
Twenty years after the Columbia disaster, what can we learn from the mistake of ignoring problems?
Every January, NASA holds a Day of Remembrance to honor the lives of astronauts lost to tragedy. But perhaps the greatest tribute we can make is to learn from past mistakes.
Comment policyComments are welcomed and encouraged on this site, but there are some instances where comments will be edited or deleted as follows: